Table 4 Multivariable Logistic regression analysis of women with multiple sclerosis and sexual dysfunction
From: Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life
Characteristic | Unadjusted odds ratio (95% CI) | P | Adjusted odds ratio (95% CI) | P* |
|---|---|---|---|---|
Age (years) | 1.032 (0.997 to 1.069) | 0.073 | 1.133 (0.933 to 1.306) | 0.085 |
Marriage duration (years) | 1.020 (0.990 to 1.050) | 0.193 | 0.981 (0.918 to 1.047) | 0. 559 |
Fatigue | 1.254 (1.064 to 1.478) | 0.007 | 1.228 (1.003 to 1.504) | 0.047 |
EDSS* | 1.101 (0.957 to 1.267) | 0.177 | 0.987 (0.788 to 1.235) | 0.907 |
BMI** | 1.071(1.004 to 1.143) | 0.037 | 1.071 (0.998 to 1.149) | 0.055 |
Depression | 1.013 (0.986 to 1.040) | 0.355 | 1.023 (0.973 to 1.076) | 0.367 |
Anxiety | 1.008 (0.981 to 1.036) | 0.572 | 1.012 (0.962 to 1.065) | 0. 638 |
Stress | 0.999 (0.975 to 1.024) | 0.938 | 0.971 (0.925 to 1.019) | 0. 230 |
Disease duration(years) | 1.015 (0.969 to 1.063) | 0.540 | 0.916 (0.803 to 1.046) | 0.195 |
Age at diagnosis(years) | 1.011(9.979 to 1.045) | 0.532 | 0.920(0.813 to 1.041) | 0.184 |
Disease Modifying Therapy(DMT) | 1.149(0.700–1.887) | 0.583 | 1.002(0.574 to 1.749) | 0.994 |
Antidepressants drugs | 0.520(0.255–1.060 | 0.072 | 0.641(0.294 to 1.398) | 0.264 |
Anticonvultion drugs | 0.541(0.258 to 1.137) | 0. 105 | 0.708(0.311 to 1.609) | 0.410 |
Antispasmodic drugs | 0.827(0.384 to 1.785) | 0.629 | 1.099(0.440 to 2.745) | 0.840 |
Course disease | ||||
 Relapsing remitting | 0.878 (9.302 to 2.553) | 0.812 | 0.806 (0. 328 to 1.979) | 0. 638 |
 Progressive | 1.115 (.317 to 3.921) | 0.865 | 0.807 (0.420 to 1.551) | 0.520 |
 CIS*** | Ref |  | ||
education | ||||
 Secondary school or below | 1.145(0.582–2.255) | 0.694 | 0.806(0.328 to 1.979) | 0.638 |
 High school | 0.942(0.530–1.674) | 0.838 | 0.807(0.420 to 1.551) | 0.520 |
 University | Ref |  | ||